What is LOPJLB’s current signal on CGON?

LOPJLB’s latest quantitative signal on CG Oncology Inc. (CGON) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CGON in?

CG Oncology Inc. (CGON) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does CG Oncology Inc. (CGON) do?

CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The companyâs product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 cl…